特里弗鲁里丁和提皮拉西尔化水化合物组合诱导的间歇性肺炎:一个病例报告
Shun Nakazawa1, Motoyasu Kato1, Yuriko Terayama1
1Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.
International medical case reports journal
|February 12, 2024
概括
一名患有晚期直肠癌的患者在三里丁和提皮拉西尔化物 (TAS-102) 化疗后出现了严重的肺部问题. 及时的皮质类固醇治疗解决了这些症状,允许恢复替代癌症疗法.
科学领域:
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 一名62岁的男性患有晚期直肠癌,最初接受了用capecitabine,oxaliplatin和bevacizumab的化疗.
- 由于皮肤皮疹,治疗被停止,随后开始治疗trifluridine和tipiracil化 (TAS-102).
更多相关视频
11:36Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
3.0K
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
8.3K
